BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Progen Pharmaceuticals Limited Says Cancer Drug Fails to Meet Main Goal

  September 24, 2007

   · 

  3 min read
• Business

  Kensey Nash Corporation Mulls Strategic Options for Endovascular Business; Announces $25 Million Stock Repurchase Program

  September 24, 2007

   · 

  6 min read
• Business

  Micrus Endovascular Corporation Board of Directors Names CEO John Kilcoyne Chairman and Promotes Robert Stern to President

  September 24, 2007

   · 

  1 min read
• Deals

  Bristol-Myers Squibb (Jobs) to Buy Partner Adnexus Therapeutics for $430 Million

  September 24, 2007

   · 

  7 min read
• FDA

  Q-Med AB Obtains Approval for MACROLANETM VRF in Europe

  September 24, 2007

   · 

  1 min read
• FDA

  ISTO Technologies, Inc. Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender

  September 24, 2007

   · 

  2 min read
• Drug Development

  Sonus Pharmaceuticals, Inc. Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel Does Not Meet Primary Endpoint

  September 24, 2007

   · 

  3 min read
• Biotech Beach

  BioSpace, 2008 Biotechnology Industry Organization (BIO) International Convention and BIOCOM Launch 9th Edition of Biotech Beach Hotbed Map Campaign

  September 24, 2007

   · 

  3 min read
• Deals

  AstraZeneca PLC to Pay Up to $310 Million for Verus Pharmaceuticals’ Asthma Programs

  September 24, 2007

   · 

  4 min read
• Deals

  Elixir Pharmaceuticals Plans $86.25 Million IPO

  September 24, 2007

   · 

  1 min read